Anson Funds Management’s ImmunoCellular Therapeutics Ltd. IMUC.WS Stock Holding History

Anson Funds Management’s Portfolio IMUC.WS Stock Details IMUC.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-117,187	Closed	-$30K	–	29
2018 Q2	$30K	Sell	117,187 -1	-0%	–	0.02%	25
2018 Q1	$29K	Hold	117,188	–	–	0.02%	25
2017 Q4	$37K	Hold	117,188	–	–	0.03%	56
2017 Q3	$44K	Hold	117,188	–	–	0.01%	53
2017 Q2	$100K	Hold	117,188	–	–	0.03%	45
2017 Q1	$373K	Hold	117,188	–	–	0.15%	33
2016 Q4	$240K	Buy	+117,188	New	+$39.9K	0.08%	72

Other funds holding IMUC.WS

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Anson Funds Management's IMUC.WS Position: Q3 2018 in Review

Anson Funds Management sold out of ImmunoCellular Therapeutics Ltd. (IMUC.WS) in Q3 2018, closing a stake of 117,187 shares — an estimated $30K sold.

Anson Funds Management first reported a position in IMUC.WS in Q4 2016 and held it in 7 quarters. The position peaked at $373K in Q1 2017. 2 funds tracked by Wall St. Rank hold IMUC.WS as of Q3 2018.

Anson Funds Management reported no remaining ImmunoCellular Therapeutics Ltd. position as of Q3 2018 after selling out during the quarter.
Anson Funds Management sold 117,187 ImmunoCellular Therapeutics Ltd. shares in Q3 2018, an estimated $30K.
Anson Funds Management first reported a position in ImmunoCellular Therapeutics Ltd. in Q4 2016 and held it in 7 quarters.
Anson Funds Management's ImmunoCellular Therapeutics Ltd. position peaked at $373K in Q1 2017.
2 funds tracked by Wall St. Rank held ImmunoCellular Therapeutics Ltd. as of Q3 2018.

Based on Anson Funds Management's 13F filing for Q3 2018, filed 14 Nov 2018.